Alector Inc

Research Alector Inc (ALEC) on Bullrun: market cap USD 230.93M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerALEC
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 230.93M
• Financial periodFY2025
• RevenueUSD 21.05M
• Revenue growth-79.1%
• Net income-USD 143.00M
• Free cash flow-USD 184.07M

Valuation Snapshot

latest market cap is USD 230.93M.

About Alector Inc

Alector, Inc., a clinical stage biotechnology company, develops therapies to counteract the progression of neurodegeneration in the United States. Its pipeline includes Nivisnebart, an investigational human recombinant monoclonal antibody for treating prevalent neurodegenerative diseases; AL137, an anti-amyloid beta antibody paired in preclinical development for the potential treatment of Alzheimer's disease;

Frequently asked questions

What is Alector Inc's market cap?

Alector Inc's market capitalization is USD 230.93M.

What does Alector Inc do?

Alector, Inc., a clinical stage biotechnology company, develops therapies to counteract the progression of neurodegeneration in the United States. Its pipeline includes Nivisnebart, an investigational human recombinant monoclonal antibody for treating prevalent neurodegenerative diseases;